Riskpilot← Back to searchSign inGet full accessWOUNDS AS
ASActiveOrg 916669283Heiane 31, 5412 StordMedical specialists activities · NACE 8622Est. 20160 employees
Revenue 2025
NOK 369K
+6% vs 2024
EBITDA margin
19.1%
-36% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
NOK 55K
-35% vs 2024
| Revenue | NOK 369K | +6% |
| EBITDA | NOK 70K | -36% |
| Net profit | NOK 55K | -35% |
| Total assets | NOK 212K | -15% |
| Equity | NOK 142K | +62% |
| Employees | 0 | — |
Legal name
WOUNDS AS
Org number
916669283
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
2. februar 2016
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Legevirksomhet spesialisert innen behandling, konsulentvirksomhet og utvikling av produkter innen sår og sårbehandling, generell kirurgi, undervisning, herunder drift av medisinsk nettside med utdanningsformål, samt alt annet som naturlig faller inn under dette.
Address
Heiane 31, 5412 Stord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 264 | 265 | 290 | 347 | 369 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 135 | 114 | 77 | 111 | 70 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 135 | 114 | 77 | 111 | 70 |
| Net financials | 0 | −0 | −0 | −3 | −0 |
| Profit before tax | 135 | 114 | 77 | 108 | 70 |
| Tax | −0 | 3 | 18 | 24 | 15 |
| Net profit | 135 | 111 | 60 | 84 | 55 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 217 | 298 | 310 | 248 | 212 |
| Equity | −167 | −56 | 4 | 88 | 142 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 385 | 354 | 306 | 160 | 69 |
| Total debt | 385 | 354 | 306 | 160 | 69 |
EBITDA margin
19.1%
This company
15.8%
Market median
+21% vs market
20212025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20212025
Return on equity
38.4%
This company
18.4%
Market median
+109% vs market
20212025
Net profit margin
14.8%
This company
8.1%
Market median
+83% vs market
20212025
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
20212025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BE Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WOUNDS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bodo Erhardt Günther | Chief Executive Officer | 0 companies |
| Isabella Stokka Landmark | Board of Directors | 0 companies |